{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T18:01:02Z","timestamp":1778522462162,"version":"3.51.4"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T00:00:00Z","timestamp":1735948800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T00:00:00Z","timestamp":1735948800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s00210-024-03741-0","type":"journal-article","created":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T08:43:45Z","timestamp":1735980225000},"page":"7489-7504","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Investigating the efficacy of gliclazide encapsulated hydrogel in the preclinical mice model for atopic dermatitis"],"prefix":"10.1007","volume":"398","author":[{"given":"Kalpana","family":"Mamale","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shalini","family":"Shukla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priyanka","family":"Mahale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akshada","family":"Mhaske","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravinder K.","family":"Kaundal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rahul","family":"Shukla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,4]]},"reference":[{"key":"3741_CR1","doi-asserted-by":"publisher","first-page":"117458","DOI":"10.1016\/J.LFS.2020.117458","volume":"247","author":"NF Abdelkader","year":"2020","unstructured":"Abdelkader NF, Eitah HE, Maklad YA et al (2020) New combination therapy of gliclazide and quercetin for protection against STZ-induced diabetic rats. Life Sci 247:117458. https:\/\/doi.org\/10.1016\/J.LFS.2020.117458","journal-title":"Life Sci"},{"key":"3741_CR2","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/J.SEMCDB.2023.04.005","volume":"154","author":"S Akhtar","year":"2024","unstructured":"Akhtar S, Alsayed RKME, Ahmad F et al (2024) Epigenetic control of inflammation in atopic dermatitis. Semin Cell Dev Biol 154:199\u2013207. https:\/\/doi.org\/10.1016\/J.SEMCDB.2023.04.005","journal-title":"Semin Cell Dev Biol"},{"key":"3741_CR3","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.45965","author":"S Al-Badawi","year":"2023","unstructured":"Al-Badawi S, Ahmed N, Akber M (2023) Acute exfoliative dermatitis\/erythroderma secondary to gliclazide. Cureus. https:\/\/doi.org\/10.7759\/cureus.45965","journal-title":"Cureus"},{"key":"3741_CR4","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/BS.PODRM.2017.02.003","volume":"42","author":"FAM Al-Omary","year":"2017","unstructured":"Al-Omary FAM (2017) Gliclazide. Profiles Drug Subst Excip Relat Methodol 42:125\u2013192. https:\/\/doi.org\/10.1016\/BS.PODRM.2017.02.003","journal-title":"Profiles Drug Subst Excip Relat Methodol"},{"key":"3741_CR5","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1080\/07435800500371805","volume":"31","author":"G Alper","year":"2005","unstructured":"Alper G, Irer S, Duman E et al (2005) Effect of I-deprenyl and gliclazide on oxidant stress\/antioxidant status and dna damage in a diabetic rat model. Endocr Res 31:199\u2013212. https:\/\/doi.org\/10.1080\/07435800500371805","journal-title":"Endocr Res"},{"key":"3741_CR6","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/j.jsps.2023.04.004","volume":"31","author":"SA Al-Suwayeh","year":"2023","unstructured":"Al-Suwayeh SA, Badran MM, Alhumoud GO et al (2023) Design and dermatokinetic appraisal of lornoxicam-loaded ultrafine self-nanoemulsion hydrogel for the management of inflammation: In vitro and in vivo studies. Saudi Pharm J 31:889\u2013903. https:\/\/doi.org\/10.1016\/j.jsps.2023.04.004","journal-title":"Saudi Pharm J"},{"key":"3741_CR7","doi-asserted-by":"publisher","first-page":"114439","DOI":"10.1016\/J.BCP.2021.114439","volume":"185","author":"T Andoh","year":"2021","unstructured":"Andoh T, Yoshihisa Y, Rehman MU et al (2021) Berberine induces anti-atopic dermatitis effects through the downregulation of cutaneous EIF3F and MALT1 in NC\/Nga mice with atopy-like dermatitis. Biochem Pharmacol 185:114439. https:\/\/doi.org\/10.1016\/J.BCP.2021.114439","journal-title":"Biochem Pharmacol"},{"key":"3741_CR8","doi-asserted-by":"publisher","first-page":"104145","DOI":"10.1016\/J.JDDST.2022.104145","volume":"80","author":"S Atmakuri","year":"2023","unstructured":"Atmakuri S, Nene S, Jain H et al (2023) Topical delivery of tofacitinib citrate loaded novel nanoemulgel for the management of 2,4-Dichlorodinitrobenzene induced atopic dermatitis in mice model. J Drug Deliv Sci Technol 80:104145. https:\/\/doi.org\/10.1016\/J.JDDST.2022.104145","journal-title":"J Drug Deliv Sci Technol"},{"key":"3741_CR9","doi-asserted-by":"publisher","first-page":"2100028","DOI":"10.1002\/adtp.202100028","volume":"4","author":"AI Barbosa","year":"2021","unstructured":"Barbosa AI, Torres T, Lima SAC, Reis S (2021) Hydrogels: a promising vehicle for the topical management of atopic dermatitis. Adv Ther (Weinh) 4:2100028. https:\/\/doi.org\/10.1002\/adtp.202100028","journal-title":"Adv Ther (Weinh)"},{"key":"3741_CR10","doi-asserted-by":"publisher","first-page":"439","DOI":"10.2147\/DMSO.S234665","volume":"13","author":"R Bened\u00e9-Ubieto","year":"2020","unstructured":"Bened\u00e9-Ubieto R, Est\u00e9vez-V\u00e1zquez O, Ramadori P et al (2020) <p>Guidelines and considerations for metabolic tolerance tests in mice<\/p>. Diabetes Metab Syndr Obes 13:439\u2013450. https:\/\/doi.org\/10.2147\/DMSO.S234665","journal-title":"Diabetes Metab Syndr Obes"},{"key":"3741_CR11","doi-asserted-by":"publisher","first-page":"110","DOI":"10.4172\/2155-9899.1000110","volume":"2","author":"EB Brandt","year":"2011","unstructured":"Brandt EB, Sivaprasad U (2011) Th2 cytokines and atopic dermatitis. J Clin Cell Immunol 2:110. https:\/\/doi.org\/10.4172\/2155-9899.1000110","journal-title":"J Clin Cell Immunol"},{"key":"3741_CR12","unstructured":"Ch M, Ey (2016) Formulation and evaluation of gliclazide loaded liposomes"},{"key":"3741_CR13","doi-asserted-by":"publisher","first-page":"121656","DOI":"10.1016\/J.IJPHARM.2022.121656","volume":"618","author":"A Cl\u00e1udia Paiva-Santos","year":"2022","unstructured":"Cl\u00e1udia Paiva-Santos A, Gama M, Peixoto D et al (2022) Nanocarrier-based dermopharmaceutical formulations for the topical management of atopic dermatitis. Int J Pharm 618:121656. https:\/\/doi.org\/10.1016\/J.IJPHARM.2022.121656","journal-title":"Int J Pharm"},{"key":"3741_CR14","doi-asserted-by":"publisher","first-page":"316131","DOI":"10.3389\/FIMMU.2017.01676\/BIBTEX","volume":"8","author":"K Clayton","year":"2017","unstructured":"Clayton K, Vallejo AF, Davies J et al (2017) Langerhans cells-programmed by the epidermis. Front Immunol 8:316131. https:\/\/doi.org\/10.3389\/FIMMU.2017.01676\/BIBTEX","journal-title":"Front Immunol"},{"key":"3741_CR15","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.3390\/pharmaceutics13091351","volume":"13","author":"M Dabbaghi","year":"2021","unstructured":"Dabbaghi M, Namjoshi S, Panchal B et al (2021) Viscoelastic and deformation characteristics of structurally different commercial topical systems. Pharmaceutics 13:1351. https:\/\/doi.org\/10.3390\/pharmaceutics13091351","journal-title":"Pharmaceutics"},{"key":"3741_CR16","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1007\/s004030050189","volume":"289","author":"TE Damsgaard","year":"1997","unstructured":"Damsgaard TE, Olesen AB, S\u00f8rensen FB et al (1997) Mast cells and atopic dermatitis. Stereological quantification of mast cells in atopic dermatitis and normal human skin. Arch Dermatol Res 289:256\u2013260. https:\/\/doi.org\/10.1007\/s004030050189","journal-title":"Arch Dermatol Res"},{"key":"3741_CR17","doi-asserted-by":"publisher","first-page":"e20180211","DOI":"10.1590\/1678-7757-2018-0211","volume":"27","author":"AA de Ara\u00fajo","year":"2019","unstructured":"de Ara\u00fajo AA, de Morais HB, de Medeiros CACX et al (2019) Gliclazide reduced oxidative stress, inflammation, and bone loss in an experimental periodontal disease model. J Appl Oral Sci 27:e20180211. https:\/\/doi.org\/10.1590\/1678-7757-2018-0211","journal-title":"J Appl Oral Sci"},{"key":"3741_CR18","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1080\/09553002.2023.2204914","volume":"99","author":"OA El-Kawy","year":"2023","unstructured":"El-Kawy OA, Ibrahim IT, Shewatah HA, Attalah KM (2023) Preparation and evaluation of radiolabeled gliclazide parenteral nanoemulsion as a new tracer for pancreatic \u03b2-cells mass. Int J Radiat Biol 99:1738\u20131748. https:\/\/doi.org\/10.1080\/09553002.2023.2204914","journal-title":"Int J Radiat Biol"},{"key":"3741_CR19","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/0003-9861(59)90090-6","volume":"82","author":"GL Ellman","year":"1959","unstructured":"Ellman GL (1959) Tissue sulfhydryl groups. Arch Biochem Biophys 82:70\u201377. https:\/\/doi.org\/10.1016\/0003-9861(59)90090-6","journal-title":"Arch Biochem Biophys"},{"key":"3741_CR20","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/J.JFDA.2018.06.007","volume":"27","author":"A Gedawy","year":"2019","unstructured":"Gedawy A, Al-Salami H, Dass CR (2019) Development and validation of a new analytical HPLC method for simultaneous determination of the antidiabetic drugs, metformin and gliclazide. J Food Drug Anal 27:315\u2013322. https:\/\/doi.org\/10.1016\/J.JFDA.2018.06.007","journal-title":"J Food Drug Anal"},{"key":"3741_CR21","doi-asserted-by":"crossref","unstructured":"Giustarini D, Rossi R, Milzani A, Dalle\u2010Donne I (2008) Nitrite and Nitrate Measurement by Griess Reagent in Human Plasma: Evaluation of Interferences and Standardization. pp 361\u2013380","DOI":"10.1016\/S0076-6879(07)00823-3"},{"key":"3741_CR22","doi-asserted-by":"publisher","DOI":"10.5772\/36975","author":"AM Grillet","year":"2012","unstructured":"Grillet AM, Wyatt NB, Gloe L (2012) Polymer gel rheology and adhesion. Rheology. https:\/\/doi.org\/10.5772\/36975","journal-title":"Rheology"},{"key":"3741_CR23","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/DER.0000000000000895","volume":"33","author":"JM Hanifin","year":"2022","unstructured":"Hanifin JM, Baghoomian W, Grinich E et al (2022) The Eczema Area and Severity Index\u2014A practical guide. Dermatitis 33:187\u2013192. https:\/\/doi.org\/10.1097\/DER.0000000000000895","journal-title":"Dermatitis"},{"key":"3741_CR24","doi-asserted-by":"publisher","first-page":"153708","DOI":"10.1016\/j.phymed.2021.153708","volume":"91","author":"DH Hwang","year":"2021","unstructured":"Hwang DH, Koh P-O, Kang C, Kim E (2021) Rosa davurica Pall. improves DNCB-induced atopic dermatitis in mice and regulated TNF-Alpa\/IFN-gamma-induced skin inflammatory responses in HaCaT cells. Phytomedicine 91:153708. https:\/\/doi.org\/10.1016\/j.phymed.2021.153708","journal-title":"Phytomedicine"},{"key":"3741_CR25","doi-asserted-by":"publisher","first-page":"173874","DOI":"10.1016\/j.ejphar.2021.173874","volume":"894","author":"H Jahan","year":"2021","unstructured":"Jahan H, Choudhary MI (2021) Gliclazide alters macrophages polarization state in diabetic atherosclerosis in vitro via blocking AGE-RAGE\/TLR4-reactive oxygen species-activated NF-k\u03b2 nexus. Eur J Pharmacol 894:173874. https:\/\/doi.org\/10.1016\/j.ejphar.2021.173874","journal-title":"Eur J Pharmacol"},{"key":"3741_CR26","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1016\/J.JACI.2009.03.032","volume":"123","author":"JM Jensen","year":"2009","unstructured":"Jensen JM, Pfeiffer S, Witt M et al (2009) Different effects of pimecrolimus and betamethasone on the skin barrier in patients with atopic dermatitis. J Allergy Clin Immunol 123:1124\u20131133. https:\/\/doi.org\/10.1016\/J.JACI.2009.03.032","journal-title":"J Allergy Clin Immunol"},{"key":"3741_CR27","doi-asserted-by":"publisher","first-page":"7160","DOI":"10.3390\/IJMS21197160","volume":"21","author":"H Jeong","year":"2020","unstructured":"Jeong H, Shin JY, Lee K et al (2020) Caffeoyl-prolyl-histidine amide inhibits fyn and alleviates atopic dermatitis-like phenotypes via suppression of NF-\u03baB activation. Int J Mol Sci 21:7160. https:\/\/doi.org\/10.3390\/IJMS21197160","journal-title":"Int J Mol Sci"},{"key":"3741_CR28","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1111\/J.1346-8138.2009.00662.X","volume":"36","author":"N Katoh","year":"2009","unstructured":"Katoh N (2009) Future perspectives in the treatment of atopic dermatitis. J Dermatol 36:367\u2013376. https:\/\/doi.org\/10.1111\/J.1346-8138.2009.00662.X","journal-title":"J Dermatol"},{"key":"3741_CR29","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1046\/j.0022-202x.2001.01374.x","volume":"116","author":"S Kaur","year":"2001","unstructured":"Kaur S, Eisen M, Zilmer M et al (2001) Patients with allergic and irritant contact dermatitis are characterized by striking change of iron and oxidized glutathione status in nonlesional area of the skin. J Invest Dermatol 116:886\u2013890. https:\/\/doi.org\/10.1046\/j.0022-202x.2001.01374.x","journal-title":"J Invest Dermatol"},{"key":"3741_CR30","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/J.JACI.2022.09.011","volume":"151","author":"YH Keith","year":"2023","unstructured":"Keith YH, Honda T, Ono S et al (2023) Infiltration and local differentiation of bone marrow-derived integrin\u03b27-positive mast cell progenitors in atopic dermatitis-like skin. J Allergy Clin Immunol 151:159-171.e8. https:\/\/doi.org\/10.1016\/J.JACI.2022.09.011","journal-title":"J Allergy Clin Immunol"},{"key":"3741_CR31","doi-asserted-by":"publisher","first-page":"207","DOI":"10.4168\/AAIR.2018.10.3.207","volume":"10","author":"BE Kim","year":"2018","unstructured":"Kim BE, Leung DYM (2018) Significance of skin barrier dysfunction in atopic dermatitis. Allergy Asthma Immunol Res 10:207\u2013215. https:\/\/doi.org\/10.4168\/AAIR.2018.10.3.207","journal-title":"Allergy Asthma Immunol Res"},{"key":"3741_CR32","doi-asserted-by":"publisher","first-page":"2903","DOI":"10.3390\/nu16172903","volume":"16","author":"HH Kim","year":"2024","unstructured":"Kim HH, Jeong SH, Park MY et al (2024) The skin histopathology of pro- and parabiotics in a mouse model of atopic dermatitis. Nutrients 16:2903. https:\/\/doi.org\/10.3390\/nu16172903","journal-title":"Nutrients"},{"key":"3741_CR33","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/s40257-022-00712-0","volume":"23","author":"E Kleinman","year":"2022","unstructured":"Kleinman E, Laborada J, Metterle L, Eichenfield LF (2022) What\u2019s New in Topicals for Atopic Dermatitis? Am J Clin Dermatol 23:595\u2013603. https:\/\/doi.org\/10.1007\/s40257-022-00712-0","journal-title":"Am J Clin Dermatol"},{"key":"3741_CR34","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1080\/08982104.2021.1880436","volume":"32","author":"P Kumar","year":"2022","unstructured":"Kumar P, Sharma DK, Ashawat MS (2022) Topical creams of piperine loaded lipid nanocarriers for management of atopic dermatitis: development, characterization, and in vivo investigation using BALB\/c mice model. J Liposome Res 32:62\u201373. https:\/\/doi.org\/10.1080\/08982104.2021.1880436","journal-title":"J Liposome Res"},{"key":"3741_CR35","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s13346-012-0060-8","volume":"2","author":"MS Lalan","year":"2012","unstructured":"Lalan MS, Laddha NC, Lalani J et al (2012) Suppression of cytokine gene expression and improved therapeutic efficacy of microemulsion-based tacrolimus cream for atopic dermatitis. Drug Deliv Transl Res 2:129\u2013141. https:\/\/doi.org\/10.1007\/s13346-012-0060-8","journal-title":"Drug Deliv Transl Res"},{"key":"3741_CR36","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1166\/jnd.2013.1008","volume":"1","author":"MS Lalan","year":"2013","unstructured":"Lalan MS, Laddha NC, Lalani J et al (2013) Dose reduction of a potent topical corticosteroid with microemulsion based cream. J Nanopharm Drug Deliv 1:52\u201363. https:\/\/doi.org\/10.1166\/jnd.2013.1008","journal-title":"J Nanopharm Drug Deliv"},{"key":"3741_CR37","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1615\/CritRevTherDrugCarrierSyst.2015012114","volume":"32","author":"M Lalan","year":"2015","unstructured":"Lalan M, Baweja J, Misra A (2015) Atopic dermatitis: drug delivery approaches in disease management. Crit Rev Ther Drug Carrier Syst 32:323\u2013361. https:\/\/doi.org\/10.1615\/CritRevTherDrugCarrierSyst.2015012114","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"key":"3741_CR38","doi-asserted-by":"publisher","first-page":"390","DOI":"10.2174\/2210681209666181226153741","volume":"10","author":"M Lalan","year":"2020","unstructured":"Lalan M, Shah P, Shah K, Prasad A (2020) Developmental studies of curcumin NLCs as safe alternative in management of infectious childhood dermatitis. Nanosci Nanotechnol Asia 10:390\u2013403. https:\/\/doi.org\/10.2174\/2210681209666181226153741","journal-title":"Nanosci Nanotechnol Asia"},{"key":"3741_CR39","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3390\/cosmetics8030069","volume":"8","author":"M Luki\u0107","year":"2021","unstructured":"Luki\u0107 M, Panteli\u0107 I, Savi\u0107 SD (2021) Towards optimal ph of the skin and topical formulations: from the current state of the art to tailored products. Cosmetics 8:69. https:\/\/doi.org\/10.3390\/cosmetics8030069","journal-title":"Cosmetics"},{"issue":"Suppl 1","key":"3741_CR40","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1159\/000370220","volume":"66","author":"S Nutten","year":"2015","unstructured":"Nutten S (2015) Atopic dermatitis: global epidemiology and risk factors. Ann Nutr Metab 66(Suppl 1):8\u201316. https:\/\/doi.org\/10.1159\/000370220","journal-title":"Ann Nutr Metab"},{"key":"3741_CR41","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","volume":"95","author":"H Ohkawa","year":"1979","unstructured":"Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351\u2013358. https:\/\/doi.org\/10.1016\/0003-2697(79)90738-3","journal-title":"Anal Biochem"},{"key":"3741_CR42","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1136\/BMJ.289.6445.605","volume":"289","author":"AD Ormerod","year":"1984","unstructured":"Ormerod AD, White MI (1984) Dermatitis. Br Med J (Clin Res Ed) 289:605. https:\/\/doi.org\/10.1136\/BMJ.289.6445.605","journal-title":"Br Med J (Clin Res Ed)"},{"key":"3741_CR43","doi-asserted-by":"publisher","first-page":"101775","DOI":"10.1016\/J.JDDST.2020.101775","volume":"57","author":"A Qadir","year":"2020","unstructured":"Qadir A, Aqil M, Ali A et al (2020) Nanostructured lipidic carriers for dual drug delivery in the management of psoriasis: Systematic optimization, dermatokinetic and preclinical evaluation. J Drug Deliv Sci Technol 57:101775. https:\/\/doi.org\/10.1016\/J.JDDST.2020.101775","journal-title":"J Drug Deliv Sci Technol"},{"key":"3741_CR44","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1080\/17425247.2021.1856071","volume":"18","author":"VK Rapalli","year":"2021","unstructured":"Rapalli VK, Singhvi G (2021) Dermato-pharmacokinetic: assessment tools for topically applied dosage forms. Expert Opin Drug Deliv 18:423\u2013426. https:\/\/doi.org\/10.1080\/17425247.2021.1856071","journal-title":"Expert Opin Drug Deliv"},{"key":"3741_CR45","doi-asserted-by":"publisher","first-page":"111945","DOI":"10.1016\/j.colsurfb.2021.111945","volume":"206","author":"VK Rapalli","year":"2021","unstructured":"Rapalli VK, Sharma S, Roy A, Singhvi G (2021) Design and dermatokinetic evaluation of Apremilast loaded nanostructured lipid carriers embedded gel for topical delivery: A potential approach for improved permeation and prolong skin deposition. Colloids Surf B Biointerfaces 206:111945. https:\/\/doi.org\/10.1016\/j.colsurfb.2021.111945","journal-title":"Colloids Surf B Biointerfaces"},{"key":"3741_CR46","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1021\/MP300722F","volume":"10","author":"K Raza","year":"2013","unstructured":"Raza K, Singh B, Singla S et al (2013) Nanocolloidal carriers of isotretinoin: antimicrobial activity against Propionibacterium acnes and dermatokinetic modeling. Mol Pharm 10:1958\u20131963. https:\/\/doi.org\/10.1021\/MP300722F","journal-title":"Mol Pharm"},{"key":"3741_CR47","unstructured":"Rowe R, Sheskey P, Quinn ME (1994) Handbook of Pharmaceutical Excipients"},{"key":"3741_CR48","doi-asserted-by":"publisher","first-page":"3090","DOI":"10.1016\/j.fct.2011.08.018","volume":"49","author":"BD Sahu","year":"2011","unstructured":"Sahu BD, Rentam KKR, Putcha UK et al (2011) Carnosic acid attenuates renal injury in an experimental model of rat cisplatin-induced nephrotoxicity. Food Chem Toxicol 49:3090\u20133097. https:\/\/doi.org\/10.1016\/j.fct.2011.08.018","journal-title":"Food Chem Toxicol"},{"key":"3741_CR49","doi-asserted-by":"publisher","first-page":"636","DOI":"10.3390\/nano12040636","volume":"12","author":"K Saini","year":"2022","unstructured":"Saini K, Modgill N, Singh K, Kakkar V (2022) Tetrahydrocurcumin lipid nanoparticle based gel promotes penetration into deeper skin layers and alleviates atopic dermatitis in 2,4-Dinitrochlorobenzene (DNCB) mouse model. Nanomaterials 12:636. https:\/\/doi.org\/10.3390\/nano12040636","journal-title":"Nanomaterials"},{"key":"3741_CR50","doi-asserted-by":"publisher","first-page":"407","DOI":"10.2174\/156720111795768013","volume":"8","author":"R Sareen","year":"2011","unstructured":"Sareen R, Kumar S, Gupta DG (2011) Meloxicam carbopol-based gels: characterization and evaluation. Curr Drug Deliv 8:407\u2013415. https:\/\/doi.org\/10.2174\/156720111795768013","journal-title":"Curr Drug Deliv"},{"key":"3741_CR51","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1111\/j.1365-2230.2007.02436.x","volume":"32","author":"E Sezer","year":"2007","unstructured":"Sezer E, Ozugurlu F, Ozyurt H et al (2007) Lipid peroxidation and antioxidant status in lichen planus. Clin Exp Dermatol 32:430\u2013434. https:\/\/doi.org\/10.1111\/j.1365-2230.2007.02436.x","journal-title":"Clin Exp Dermatol"},{"key":"3741_CR52","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/J.IJPHARM.2006.07.001","volume":"326","author":"AN Shishu","year":"2006","unstructured":"Shishu AN (2006) Preparation of hydrogels of griseofulvin for dermal application. Int J Pharm 326:20\u201324. https:\/\/doi.org\/10.1016\/J.IJPHARM.2006.07.001","journal-title":"Int J Pharm"},{"key":"3741_CR53","doi-asserted-by":"publisher","first-page":"S118","DOI":"10.1016\/j.jaci.2003.09.033","volume":"112","author":"JM Spergel","year":"2003","unstructured":"Spergel JM, Paller AS (2003) Atopic dermatitis and the atopic march. J Allerg Clin Immunol 112:S118-127. https:\/\/doi.org\/10.1016\/j.jaci.2003.09.033","journal-title":"J Allerg Clin Immunol"},{"key":"3741_CR54","doi-asserted-by":"publisher","first-page":"154","DOI":"10.3109\/10717544.2014.907842","volume":"23","author":"M Srivastava","year":"2016","unstructured":"Srivastava M, Kohli K, Ali M (2016) Formulation development of novel in situ nanoemulgel (NEG) of ketoprofen for the treatment of periodontitis. Drug Deliv 23:154\u2013166. https:\/\/doi.org\/10.3109\/10717544.2014.907842","journal-title":"Drug Deliv"},{"key":"3741_CR55","doi-asserted-by":"publisher","first-page":"255","DOI":"10.3390\/gels7040255","volume":"7","author":"G Stojkov","year":"2021","unstructured":"Stojkov G, Niyazov Z, Picchioni F, Bose RK (2021) Relationship between structure and rheology of hydrogels for various applications. Gels 7:255. https:\/\/doi.org\/10.3390\/gels7040255","journal-title":"Gels"},{"key":"3741_CR56","doi-asserted-by":"publisher","first-page":"2671","DOI":"10.3390\/IJMS21082671","volume":"21","author":"R Tamagawa-Mineoka","year":"2020","unstructured":"Tamagawa-Mineoka R, Katoh N (2020) Atopic dermatitis: identification and management of complicating factors. Int J Mol Sci 21:2671. https:\/\/doi.org\/10.3390\/IJMS21082671","journal-title":"Int J Mol Sci"},{"key":"3741_CR57","doi-asserted-by":"publisher","first-page":"404","DOI":"10.2174\/1389200218666170306104042","volume":"18","author":"N Thotakura","year":"2017","unstructured":"Thotakura N, Kumar P, Wadhwa S et al (2017) Dermatokinetics as an important tool to assess the bioavailability of drugs by topical nanocarriers. Curr Drug Metab 18:404\u2013411. https:\/\/doi.org\/10.2174\/1389200218666170306104042","journal-title":"Curr Drug Metab"},{"key":"3741_CR58","doi-asserted-by":"publisher","first-page":"573","DOI":"10.3390\/nu11030573","volume":"11","author":"HR Yang","year":"2019","unstructured":"Yang HR, Lee H, Kim J-H et al (2019) Therapeutic effect of Rumex japonicus Houtt. on DNCB-Induced atopic dermatitis-like skin lesions in Balb\/c mice and human keratinocyte HaCaT cells. Nutrients 11:573. https:\/\/doi.org\/10.3390\/nu11030573","journal-title":"Nutrients"},{"key":"3741_CR59","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1177\/1203475420923644","volume":"24","author":"YB Yang","year":"2020","unstructured":"Yang YB, Lynde CW, Fleming P (2020) Common atopic dermatitis rating scales: a practical approach and brief review. J Cutan Med Surg 24:399\u2013404. https:\/\/doi.org\/10.1177\/1203475420923644","journal-title":"J Cutan Med Surg"},{"key":"3741_CR60","doi-asserted-by":"publisher","first-page":"e7703","DOI":"10.1371\/journal.pone.0007703","volume":"4","author":"EY Zhang","year":"2009","unstructured":"Zhang EY, Chen AY, Zhu BT (2009) Mechanism of dinitrochlorobenzene-induced dermatitis in mice: role of specific antibodies in pathogenesis. PLoS One 4:e7703. https:\/\/doi.org\/10.1371\/journal.pone.0007703","journal-title":"PLoS One"},{"key":"3741_CR61","doi-asserted-by":"publisher","first-page":"1081999","DOI":"10.3389\/FIMMU.2023.1081999\/BIBTEX","volume":"14","author":"C Zheng","year":"2023","unstructured":"Zheng C, Shi Y, Zou Y (2023) T cell co-stimulatory and co-inhibitory pathways in atopic dermatitis. Front Immunol 14:1081999. https:\/\/doi.org\/10.3389\/FIMMU.2023.1081999\/BIBTEX","journal-title":"Front Immunol"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-024-03741-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-024-03741-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-024-03741-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T10:51:18Z","timestamp":1748602278000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-024-03741-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,4]]},"references-count":61,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["3741"],"URL":"https:\/\/doi.org\/10.1007\/s00210-024-03741-0","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,4]]},"assertion":[{"value":"10 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All institutional and national guidelines for the care and use of laboratory animals were followed.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval (CCSEA) for animal studies was approved by IAEC committee of National institute of Pharmaceutical Education and Research Raebareli.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}